The University of Chicago Header Logo

Connection

Stephen Hanauer to Drug Tolerance

Back to Details
This is a "connection" page, showing publications Stephen Hanauer has written about Drug Tolerance.
Stephen Hanauer
Connection Strength
0.015
Drug Tolerance
  1. An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol. 2004 Oct; 99(10):1984-9.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.